iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F18%3A00491888" target="_blank" >RIV/61388963:_____/18:00491888 - isvavai.cz</a>
Result on the web
<a href="https://elifesciences.org/articles/35032" target="_blank" >https://elifesciences.org/articles/35032</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.7554/eLife.35032" target="_blank" >10.7554/eLife.35032</a>
Alternative languages
Result language
angličtina
Original language name
iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE
Original language description
The apical inflammatory cytokine TNF regulates numerous important biological processes including inflammation and cell death, and drives inflammatory diseases. TNF secretion requires TACE (also called ADAM17), which cleaves TNF from its transmembrane tether. The trafficking of TACE to the cell surface, and stimulation of its proteolytic activity, depends on membrane proteins, called iRhoms. To delineate how the TNF/TACE/iRhom axis is regulated, we performed an immunoprecipitation/mass spectrometry screen to identify iRhom-binding proteins. This identified a novel protein, that we name iTAP (iRhom Tail-Associated Protein) that binds to iRhoms, enhancing the cell surface stability of iRhoms and TACE, preventing their degradation in lysosomes. Depleting iTAP in primary human macrophages profoundly impaired TNF production and tissues from iTAP KO mice exhibit a pronounced depletion in active TACE levels. Our work identifies iTAP as a physiological regulator of TNF signalling and a novel target for the control of inflammation.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
<a href="/en/project/LO1302" target="_blank" >LO1302: InterBioMed</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
eLife
ISSN
2050-084X
e-ISSN
—
Volume of the periodical
7
Issue of the periodical within the volume
Jun 13
Country of publishing house
GB - UNITED KINGDOM
Number of pages
35
Pages from-to
—
UT code for WoS article
000438484100001
EID of the result in the Scopus database
2-s2.0-85051591388